Context Therapeutics Inc.
For the period ended Dec 31, 2024. Filed Mar 20, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 20, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
Our corporate headquarters are located at 2001 Market Street, Suite 3915, Unit #15, Philadelphia, PA 19103, where we occupy approximately 3,500 square feet of office space pursuant to a lease that was set to expire on August 31, 2024 if we did not renew the lease for an additional year. In March 2024, we amended the lease to extend the expiration date to November 30, 2024. In July 2024, we further amended the lease, which now expires on November 30, 2026 and renews at our option for two additional successive one-year periods should we provide the landlord with notice of extension at least nine months before any such successive renewal.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.